Status:
UNKNOWN
Investigation of the Optimal Cocktailed Probiotics for Decolonization of Vancomycin-resistant Enterococci in Human Gut
Lead Sponsor:
Taipei Medical University Shuang Ho Hospital
Collaborating Sponsors:
Taipei Medical University
Delta Electronics
Conditions:
Vancomycin-Resistant Enterococci
Probiotics
Eligibility:
All Genders
20-90 years
Phase:
NA
Brief Summary
Vancomycin-resistant enterococci (VRE) has been a serious public health issue as an opportunistic pathogen and reservoir of antibiotic resistant genes. To reduce VRE carriage in human gut, investigato...
Detailed Description
Enterococci are one of the commensal gut flora in humans and have become an important pathogenic bacterium of opportunistic infection. Enterococci can cause severe infection when the patients become i...
Eligibility Criteria
Inclusion
- VRE-carriage
- of age between 20 and 90-year-old
- agreeing to participate
Exclusion
- routine probiotic uptake in daily life, or being prescribed with probiotics in clinic one- week before or in the period of clinical trial
- being prescribed with oral antibiotic uptake in the period of clinical trial
- with diarrhea symptom
- in pregnancy
- of immuno-compromised conditions or being prescribed with steroid-type medicines
- with diabetes mellitus
- critically ill patients
Key Trial Info
Start Date :
March 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03822819
Start Date
March 15 2019
End Date
September 30 2020
Last Update
March 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taipei Medical University Hospital
Taipei, Taiwan, 110